| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
8-M-PDOT manufacturers
- 8-M-PDOT
-
- $30.00
-
2026-05-11
- CAS:134865-70-6
- Purity: 99.54%
- Supply Ability: 10g
- 8-M-PDOT
-
- $30.00
-
2026-05-11
- CAS:134865-70-6
- Purity: 99.54%
- Supply Ability: 10g
- 8-M-PDOT
-
- $30.00
-
2025-07-18
- CAS:134865-70-6
- Purity: 99.54%
- Supply Ability: 10g
|
| | 8-M-PDOT Basic information |
| Product Name: | 8-M-PDOT | | Synonyms: | 8-METHOXY-2-PROPIONAMIDOTETRALIN;8-M-PDOT;AH 002;8 M PDOT,8MPDOT;Propanamide, N-(1,2,3,4-tetrahydro-8-methoxy-2-naphthalenyl)-;8-M-PDOT, 10 mM in DMSO | | CAS: | 134865-70-6 | | MF: | C14H19NO2 | | MW: | 233.31 | | EINECS: | | | Product Categories: | | | Mol File: | 134865-70-6.mol |  |
| | 8-M-PDOT Chemical Properties |
| Boiling point | 447.8±45.0 °C(Predicted) | | density | 1.09±0.1 g/cm3(Predicted) | | storage temp. | Store at RT | | solubility | Soluble to 50 mM in ethanol and to 100 mM in DMSO | | form | Powder | | pka | 15.87±0.20(Predicted) | | color | White to off-white |
| | 8-M-PDOT Usage And Synthesis |
| Description | 8-M-PDOT is a melatonin receptor 2 (MT2) agonist (Ki = 1.12 nM). It is 5.2-fold selective for MT2 over MT1 receptors in a radioligand binding assay. Striatal microinfusion of 8-M-PDOT (10 μg/μl) increases the percentage of time spent in the open arms of the elevated plus maze, indicating anxiolytic-like activity, in a rat model of rotenone-induced Parkinson''s disease. | | Uses | AH 002 is a selective melatonin receptor agonist. | | Biological Activity | Melatonin receptor agonist, 20-fold selective for the MT 2 (vs MT 1 ) subtype. At human recombinant MT 1 and MT 2 receptors, displays pK i values of 8.23 and 8.95 respectively. | | in vivo | 8-M-PDOT (10 μg/μL; administrated into the dorsal striatum by bilateral cannulas; for 30 minutes; male Wistar rats) treatment shows anxiolytic-like effect[2]. | Animal Model: | Male Wistar rats (280-320 g) with Rotenone[2] | | Dosage: | 10 μg/μL | | Administration: | Administrated into the dorsal striatum by bilateral cannulas; for 30 minutes | | Result: | Increased percentage of time spent in the open arms and in the number of open arms entries.
|
| | IC 50 | MT2 | | References | [1] CHRISTOPHER BROWNING. Pharmacological characterization of human recombinant melatonin mt1 and MT2 receptors[J]. British Journal of Pharmacology, 2009, 129 5: 877-886. DOI: 10.1038/sj.bjp.0703130 [2] ANA CAROLINA D. NOSEDA. REM sleep deprivation promotes a dopaminergic influence in the striatal MT2 anxiolytic-like effects[J]. Sleep Science, 2016, 9 1: Pages 47-54. DOI: 10.1016/j.slsci.2015.10.002 |
| | 8-M-PDOT Preparation Products And Raw materials |
|